Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H23NO3 |
Molecular Weight | 349.4229 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@]1(CC(O)=O)OC[C@H](CC2=CC=CC=C2)C3=C1NC4=C3C=CC=C4
InChI
InChIKey=BUUODSZYUAZDIF-AOMKIAJQSA-N
InChI=1S/C22H23NO3/c1-2-22(13-19(24)25)21-20(17-10-6-7-11-18(17)23-21)16(14-26-22)12-15-8-4-3-5-9-15/h3-11,16,23H,2,12-14H2,1H3,(H,24,25)/t16-,22-/m0/s1
Molecular Formula | C22H23NO3 |
Molecular Weight | 349.4229 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Dexpemedolac is long-acting non-narcotic analgesic. Dexpemedolac exhibited potent analgesic effects against chemically induced pain in rats and mice and against inflammatory pain in rats. Dexpemedolac differed from standard nonsteroidal anti-inflammatory drugs (NSAIDs) in that the doses, which produced analgesia were much lower than those required for either anti-inflammatory or gastric irritant effects. The common to the NCAIDs class actions are antipyresis and inhibitory effects on platelet aggregation. In yeast-induced hyperthermic rats, dexpemedolac exhibited antipyretic actions, whereas the drug did not affect body temperature in normothermic animals. Aggregation of human platelets was inhibited by high concentrations of dexpemedolac.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:03:19 GMT 2023
by
admin
on
Fri Dec 15 19:03:19 GMT 2023
|
Record UNII |
P7VK7RH5C7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6183
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
P7VK7RH5C7
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL2218910
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
100000082475
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
SUB09653MIG
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
C174836
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
114716-16-4
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
6918042
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
X-81
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY | |||
|
C056040
Created by
admin on Fri Dec 15 19:03:19 GMT 2023 , Edited by admin on Fri Dec 15 19:03:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |